MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Sleep disorders. See also Restless legs syndrome: Treatment"

  • MDS Virtual Congress 2021

    Effects of low frequency repetitive transcranial stimulation over right dorsolateral prefrontal region on clinical symptoms and sleep structure of Parkinson’s disease Abstract

    WU. Jing, C. Jing, Z. Sheng, LIU. Feng (Suzhou, China)

    Objective: We aim to investigate the effects of low-frequency rTMS over the dorsolateral prefrontal cortex (DLPFC) on sleep and other symptoms in PD patients. Background:…
  • MDS Virtual Congress 2021

    EFFECTIVENESS OF NEUROFUNCTIONAL PHYSICAL THERAPY ON THE QUALITY OF SLEEP OF INDIVIDUALS WITH PARKINSON’S DISEASE: A SERIES OF CASES

    R. Souza, S. Smaili, I. Almeida, M. Terra, N. Barboza, ME. Bueno, A. Mesas (Londrina, Brazil)

    Objective: To verify the effectiveness of neurofunctional physical therapy in sleep quality objectively and subjectively assess it among individuals with PD. Background: Parkinson's disease (PD)…
  • 2019 International Congress

    Mandibular Advancement Device in Parkinson’s disease: an efficacious and usable device in a disabling disease

    V. Cochen Decock, M. Castel, I. Bonafé (Montpellier, France)

    Objective: The aim of our study is to explore the efficacy, observance, and usability of Mandibular Advancement Device in patients with  Parkinson’s disease (PD) and…
  • 2019 International Congress

    Prolonged-release Melatonin for Sleep Disorders in Parkinson’s Disease: A Randomized trial

    JH. Ahn, M. Kim, JK. Mun, J. Youn, S. Park, W. Jang, J. Park, E. Oh, JW. Cho, JS. Kim (Seoul, Republic of Korea)

    Objective: To evaluate the efficacy of PRM in sleep disorders of patients with PD was investigated. Background: Sleep disorders are highly prevalent in patients with…
  • 2019 International Congress

    Effect of Speech therapy in the sleep of patients with Machado-Joseph disease (MJD) or spinocerebellar ataxia type 3 (SCA3)

    G. Diaféria, JL. Pedroso, S. Park, F. Haddad, L. Haddad, L. Prado, G. Prado, O. Barsottini (São Paulo, Brazil)

    Objective: The objective of this study was to evaluate, through polysomnography, the effect of myofunctional therapy in patients with spinocerebellar ataxia type 3. Background: SCA3/MJD…
  • 2019 International Congress

    An Internet of Things system for patient empowerment: a case study on measuring patients’ understanding of causal relationships between symptoms and behaviour

    L. Karni, M. Memedi, E. Kolkowska, I. Scandurra, P. de Roos, DA. Nyholm, G. Klein (Örebro, Sweden)

    Objective: To evaluate the ability of patients to understand causal relationships between disease symptoms and behaviour presented from synthetic representative cases using the system. Secondary…
  • 2019 International Congress

    Evaluation of the Zeez Sleep Pebble for Sleep Disturbance in Parkinson’s Disease

    S. Milne, S. Cummins, C. Carroll (Plymouth, United Kingdom)

    Objective: To evaluate the effect of the Zeez Sleep Pebble© on sleep disturbance in Parkinson’s disease. Background: Sleep disturbance is common in Parkinson’s disease (PD)…
  • 2018 International Congress

    Efficacy of prolonged release melatonin for REM sleep behaviour disorder in Parkinson’s disease: A double blind, randomised, placebo-controlled trial

    M. Gilat, R. Grunstein, N. Marshall, D. Hammond, A. Coeytaux Jackson, A. Mullins, J. Hall, S. (Sydney, Australia)

    Objective: Test the efficacy of prolonged-released melatonin for REM sleep behaviour disorder (RBD) in Parkinson’s disease (PD). Background: Half of all PD patients experience RBD…
  • 2018 International Congress

    Clonazepam for REM sleep behavior disorder in Parkinsonism: A randomized, placebo-controlled trial

    C. Shin, H. Park, W. Lee, B. Jeon, H. Kim (Seoul, Republic of Korea)

    Objective: To determine the efficacy and safety of clonazepam for the treatment of rapid eye movement (REM) sleep behavior disorder (RBD) in patients with Parkinsonism.…
  • 2018 International Congress

    Neuroprotective effect of exogenous melatonin on apoptosis of neuroadernergic neurons in a rat model of Parkinson’s disease

    F. Yadolahi, M. Mehrpour (Tehran, Islamic Republic of Iran)

    Objective: To investigate melatonin therapeutic potential effects in Parkinson’s disease. Background: Sleep disorders constitute major nonmotor features of Parkinson’s disease (PD) that have a substantial…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley